Ovarian Cancer News & Features

At only 2 years of age, McKenna Xydias is a cancer survivor.

or the study, the investigators analyzed data from the U.S. National Cancer Database. They compared nearly 36,000 women who were diagnosed and treated between 2004 and 2009, with more than 37,000 women diagnosed and treated between 2011 and 2014.

After adjusting for such factors as age and whether women had ever given birth, any use of birth control pills was associated with a 46% lower risk of death within a year of an ovarian cancer diagnosis, the study found.

Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.

Researchers say that women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23 percent lower risk of developing ovarian cancer than those who did not regularly take aspirin.

One low-dose aspirin -- the type many older women already take to help their hearts -- was tied to a 10 percent reduction in developing ovarian cancer and as much as a 30 percent improvement in survival for ovarian cancer patients, two new studies have found.

A jury says Johnson & Johnson must pay $4.62 billion to 22 women who allege they developed ovarian cancer after using the company's Baby Powder and Shower to Shower brand talcum powder as part of their daily feminine hygiene routine.

Early Success in Artificial Ovary Research An early advance in efforts to develop artificial ovaries for women with cancer who are at risk of becoming infertile has been achieved by scientists.Cancer treatments such as chemotherapy and radiotherapy, can damage the ovaries and leave women infertile. In some cases, all or part of the ovary is removed before those cancer treatments and frozen so that it can be used in the future, BBC News reported.However, there is a slight risk that the ovarian tissue may contain cancer cells, putting a woman at risk for the return of her

One study found that a new targeted "immunotherapy" to treat ovarian cancer that has come back looked promising in a small, early trial.

The researchers behind the new study developed a testing regimen called PapSEEK to see if additional samples collected during a pelvic exam could be used to detect endometrial or ovarian cancer.

Screening not only didn’t prevent any deaths, it also led to harm, the panel said.

According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well.

Award in Missouri case set aside upon appeal. Does not affect larger California award in similar suit.

Verdict was fourth against Johnson & Johnson

Ovarian Cancer Drug Given Fast-Track Approval

Leading cancer and women's health groups say probably not

Woman Gets $70M in Baby Powder/Ovarian Cancer Suit

May delay preventive therapies for high-risk women, spur unnecessary procedures in some without cancer

Because early signs are often easy to ignore, 140,000 women worldwide die of the disease every year

Rates down 16 percent in U.S., 8 percent in Canada, and 10 percent in Europe over a decade: study

Chronic inactivity linked to greater risk for the disease in study

Study found using both abdomen drip and IV delayed progression of disease

Advanced age, disease were predictors for receiving only chemo, radiation or nothing at all

Better understanding needed to improve prevention, detection, treatment, U.S. panel notes

$72M Awarded in Johnson & Johnson Baby Powder Case